Michael B. Knable - Concepedia

Author

Michael B. Knable

Also Known As

D W Black, M B Knable, M Knable, M. B. Knable, M. Knable, M.B. Knable, MICHAEL B. KNABLE, Michael B Knable, Michael B. Knable, Michael Knable

Publications

6.2K

Citations

H-Index

Concepts

All Affiliations

Stanley Foundation National Institute of Mental Health Uniformed Services University of the Health Sciences Stanley Medical Research Institute National Institutes of Health

About

Michael B. Knable is an author at Stanley Foundation specializing in medicine, neuroscience, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	26	3.7K
2	Social Sciences	18	20	2.7K
3	Health Sciences	4	4	323
4	Public Health	1	1	10
5	Behavioral Health	1	1	10

Michael B. Knable

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
The Stanley Foundation brain collection and Neuropathology Consortium Ε. Fuller Torrey, Maree J. Webster, Michael B. Knable, Schizophrenia Research Neuroimaging BiomarkersNeuroanatomyNeuroimagingNeurologyNeuroscience	2000	533
Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains Ε. Fuller Torrey, Beata M. Barci, Maree J. Webster, Biological Psychiatry Neuroimaging BiomarkersNeuropsychologyPsychiatryMajor DepressionDepression	2004	422
Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders Maree J. Webster, Michael B. Knable, J O'Grady, Molecular Psychiatry NeuropsychologyPsychiatryPsychiatric DisordersPsychotic DisorderPsychopharmacology	2002	409
Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium Michael B. Knable, Beata M. Barci, Maree J. Webster, Molecular Psychiatry NeuropsychologyPsychiatric DisordersNeuropsychiatrySocial SciencesStanley Neuropathology Consortium	2004	403
A Placebo-Controlled Trial of Omega-3 Fatty Acid (Ethyl Eicosapentaenoic Acid) Supplementation for Residual Symptoms and Cognitive Impairment in Schizophrenia Wayne S. Fenton, Faith Dickerson, John J. Boronow, American Journal of Psychiatry	2001	324
Reduced Central Serotonin Transporters in Alcoholism Andreas Heinz, Paul Ragan, Douglas W. Jones, American Journal of Psychiatry	1998	307
Deficient Hippocampal Neuron Expression of Proteasome, Ubiquitin, and Mitochondrial Genes in Multiple Schizophrenia Cohorts C. Anthony Altar, Linda W. Jurata, Vin Charles, Biological Psychiatry Alzheimer's DiseaseMolecular NeurosciencePsychiatryPsychotic DisorderPsychiatric Genetics	2005	303
Tourette Syndrome: Prediction of Phenotypic Variation in Monozygotic Twins by Caudate Nucleus D2 Receptor Binding Steven S. Wolf, Douglas W. Jones, Michael B. Knable, Science Phenotypic VariationNeuropsychologyGeneticsWithin Monozygotic TwinsNeuropsychiatry	1996	254
In Vivo Determination of Muscarinic Acetylcholine Receptor Availability in Schizophrenia Thomas J. Raedler, Michael B. Knable, Douglas W. Jones, American Journal of Psychiatry	2002	215
Immunohistochemical Localization of Phosphorylated Glial Fibrillary Acidic Protein in the Prefrontal Cortex and Hippocampus from Patients with Schizophrenia, Bipolar Disorder, and Depression Maree J. Webster, Michael B. Knable, N L Johnston-Wilson, Brain Behavior and Immunity NeuropsychologyImmunohistochemical LocalizationPsychiatryPrefrontal CortexDepression	2001	179

Page 1